ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Inflammatory Response-Related Long Non-Coding RNA Signature Predicts the Prognosis of Hepatocellular Carcinoma

Li, Xinyu; Zhang, Shuqiao; Zhang, Shijun; Kuang, Weihong; Tang, Chunzhi*广东医学院; 广州中医药大学; 中山大学; 1
Journal of Oncology2022-3-17DOI: 10.1155/2022/9917244
5被引7阅读
引用收藏
分享

摘要

Background. Hepatocellular carcinoma (HCC) is a high mortality malignant tumor with genetic and phenotypic heterogeneity, making predicting prognosis challenging. Meanwhile, the inflammatory response is an indispensable player in the tumorigenesis process and regulates the tumor microenvironment, which can affect the prognosis of tumor patients. Methods. Using HCC samples in the TCGA-LIHC dataset, we explored lncRNA expression profiles associated with the inflammatory response. The inflammatory response-related lncRNA signature was constructed by univariate Cox regression, LASSO regression, and multivariate Cox regression methods based on inflammatory response-related differentially expressed lncRNAs in HCC. Results. Seven inflammatory response-related lncRNA signatures were identified in predicting HCC prognosis. Kaplan-Meier (K-M) survival analysis indicated that high-risk group HCC patients were associated with poor prognosis. The utility of the inflammatory response-related lncRNA signatures was proved by the AUC and DCA analysis. The nomogram further confirmed the accuracy of the novel signature in predicting HCC patients' prognoses. In validation, our novel signature is more accurate than traditional clinicopathological performance for prognosis prediction of HCC patients. GSEA analysis further elucidated the underlying mechanisms and pathways of HCC progression in the low- and high-risk groups. Moreover, immune cells infiltration responses and immune function analyses revealed a significant difference between high- and low-risk groups in cytolytic activity, MHC class I, type I INF response, type II INF response, inflammation-promoting, and T cell coinhibition. Finally, HHLA2, NRP1, CD276, TNFRSF9, TNFSF4, CD80, and VTCN1 were expressed higher in high-risk groups in the immune checkpoint analysis. Conclusions. A novel inflammatory response-related lncRNA signature (AC145207.5, POLHAS1, AL928654.1, MKLN1AS, AL031985.3, PRRT3AS1, and AC023157.2) is capable of predicting the prognosis of HCC patients and providing new immune targeted therapies insight.

学科与关键词

关键词
TNF-ALPHACANCEREXPRESSION
相关
加载中…
  • Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma
    Deng, Min; Lin, Jia-Bao; Zhao, Rong-Ce; Li, Shao-Hua; Lin, Wen-Ping; Zou, Jing-Wen; Wei, Wei; Guo, Rong-Ping*BMC CANCER, 2021, 21(1): 1347.被引 3
  • Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
    Fang, Chongkai; Liu, Silin; Feng, Kunliang; Huang, Chaoyuan; Zhang, Ying; Wang, Jinan; Lin, Hongtong; Wang, Junyan*; Zhong, Chong*Scientific Reports, 2022, 12(1): 6642.被引 13
  • Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma
    Chen, Rui; Chen, Yunlong; Huang, Wenjie; Zhao, Yingnan; Luo, Wang; Lin, Jinyu; Wang, Zhuangxiong; Yang, Jian*Aging-US, 2021, 13(13): 17607-17628.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Oncology
发表日期
2022-03-17
卷期
第 2022 卷
页码
9917244
DOI
10.1155/2022/9917244
期刊等级
4区
成果收录
SCIE
资助标注
Opening Operation Program of Key Laboratory of Acupuncture and Moxibustion of Traditional Chinese Medicine in Guangdong [2017B030314143]

作者

  • L

    Li, Xinyu (第一作者)

    guangzhou univ chinese med

  • Z

    Zhang, Shuqiao

    1 · guangzhou univ chinese med

查看全部 5 位作者收起作者
  • Z

    Zhang, Shijun

    1 · sun yat sen univ

  • K

    Kuang, Weihong

    guangdong med univ

  • T

    Tang, Chunzhi (通讯)

    guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417